Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Episode 5 July 07, 2021 00:51:14
Episode 5:  Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc
Few & Far Between: How Biotech Gets Built
Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Jul 07 2021 | 00:51:14

/

Show Notes

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc, about clinical trial engagement in the rare disease patient community.

Other Episodes

Episode 26

December 07, 2022 00:39:02
Episode Cover

Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.

"Try to find the people who have a really strong background in regulatory science, who really understand the fundamentals, and who you believe can...

Listen

Episode 27

January 12, 2023 00:33:36
Episode Cover

Episode 27, Part 1: Jamie Heywood, Biotech Engineer and Entrepreneur

"I think all disciplines go through a process, a journey of being imagined and then becoming a science and then becoming a discipline of...

Listen

Episode 46

January 15, 2025 00:43:29
Episode Cover

Episode 46: Ben Olds and Amy Fenollosa, Haven Human Asset Ventures

"There's that old saying, 'culture is how people behave when nobody's looking.' So, if you want to be effective, your [mission and value statements]...

Listen